The spread of COVID-19 and the resulted lockdown imposed across the globe has negatively affected the contraceptive drugs market. Many women across the world found it hard to purchase the pills as contraceptive drug manufacturers were facing challenges due to inconsistent supply chains and the workforce. However, as the lockdown is getting lifted across the globe, the market is expected to gain traction. Due to the rise in online availability of contraceptive drugs, customers can have easy access to them, which works in favour of the market. As the growth of the market is visible to many experts and many credible market research reports are expecting a positive future, the market is witnessing some trends such as partnerships, acquisitions, launching new drugs, research and development and favourable government regulations. As per the market research report published by Allied Market Research, the global contraceptive drugs market is anticipated to reach $24,412.22 million by 2027, manifesting a CAGR of 6.9% from 2020 to 2027.